• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.27% Nasdaq Down 0.34%

    OncoMed Pharmaceuticals, Inc. (OMED)

    -NasdaqGS
    21.31 Down 0.37(1.71%) 12:55PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:21.68
    Open:21.60
    Bid:21.30 x 300
    Ask:21.36 x 100
    1y Target Est:39.25
    Beta:1.637
    Earnings Date:Aug 5 - Aug 10 (Est.)
    Day's Range:21.13 - 21.64
    52wk Range:16.57 - 29.83
    Volume:55,449
    Avg Vol (3m):139,132
    Market Cap:639.69M
    P/E (ttm):N/A
    EPS (ttm):-1.70
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for OMED

    Comparison

    Symbol% ChgMkt Cap
    OMEDDown 1.71%639.69M
    STMLDown 1.19%209.15M
    VSTMDown 1.97%255.03M

    Key Statistics

    Forward P/E (1 yr):31.32
    P/S (ttm):15.05
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.93
    Quarterly EPS Est (Jun-15) :-0.43
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    OncoMed Pharmaceuticals, Inc., a clinical development-stage biotechnology company, discovers and develops protein therapeutics targeting cancer stem cells (CSCs). View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback